Vadadustat

Chemical formula: C₁₄H₁₁ClN₂O₄  Molecular mass: 306.041 g/mol  PubChem compound: 23634441

Therapeutic indications

Vadadustat is indicated for:

Symptomatic anaemia associated with chronic kidney disease

Population group: only adults (18 years old or older)

Vadadustat is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vadadustat is contraindicated in the following cases:

Pregnancy

Pregnancy

Severe hepatic impairment

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: VAFSEO Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈